ARCHIVES

In brief: NCA Centers Subcommittee to Hammer Out New Proposals For Comprehensible Characteristics

This article is from The Cancer Letter archive.

Vol. 05 No. 39 | September 28, 1979

Download PDF Visit The Full Archive

Related Articles

Competition For Center Grants Higher In FY95, Kimes Tells BSC

November 25, 1994

Sexual Function Affected By Stem Cell Transplant

September 28, 2007

NCAB Study Core Guideline Revisions; Final Decision To Await New Division BSC

May 23, 1980

Breast Cancer Death Rates Improving, NCI Says

May 10, 1996

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

Hammer Agrees To Bush Request for FDA Probe

July 15, 1988